These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8053053)

  • 1. Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up.
    Torregrosa JV; Campistol JM; Montesinos M; Rogada AG; Oppenheimer F; Andreu J
    Transplantation; 1994 Aug; 58(3):311-4. PubMed ID: 8053053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ramipril in post-renal transplant erythrocytosis.
    Esposito R; Giammarino A; De Blasio A; Martinelli V; Cirillo F; Scopacasa F; Federico S; Russo D
    J Nephrol; 2007; 20(1):57-62. PubMed ID: 17347974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransplant erythrocytosis in renal transplant recipients at Jeddah Kidney Center, Kingdom of Saudi Arabia.
    Basri N; Gendo MZ; Haider R; Abdullah KA; Hassan A; Shaheen FA
    Exp Clin Transplant; 2007 Jun; 5(1):607-9. PubMed ID: 17617052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of posttransplant erythrocytosis with enalapril.
    Rell K; Koziak K; Jarzyo I; Lao M; Gaciong Z
    Transplantation; 1994 Apr; 57(7):1059-63. PubMed ID: 8165703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the angiotensin-converting enzyme inhibitor enalapril on post-transplant erythrocytosis.
    Marubayashi S; Yamamoto H; Shibata S; Fudaba Y; Miyata Y; Fukuma K; Okada K; Hinoi T; Ikeda M; Maeda T; Oshiro Y; Dohi K
    Hiroshima J Med Sci; 1998 Sep; 47(3):121-4. PubMed ID: 9810784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
    Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L
    Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors: efficacy, safety and action mechanisms.
    Montanaro D; Groupuzzo M; Boscutti G; Risaliti A; Bresadola F; Mioni G
    Clin Nephrol; 2000 Apr; 53(4):suppl 47-51. PubMed ID: 10809436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study.
    Kessler M; Hestin D; Mayeux D; Mertes PM; Renoult E
    Clin Nephrol; 1996 Feb; 45(2):83-9. PubMed ID: 8846535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis.
    Wang AY; Yu AW; Lam CW; Yu LM; Li PK; Goh J; Lui SF
    Am J Kidney Dis; 2002 Mar; 39(3):600-8. PubMed ID: 11877580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ACE inhibitors in the treatment of erythrocytosis in patients with renal allograft.
    Pisani F; Tisone G; Alciati E; Vennarecci G; Pieragostini E; Casciani CU
    Transplant Proc; 1994 Oct; 26(5):2602-3. PubMed ID: 7940809
    [No Abstract]   [Full Text] [Related]  

  • 11. Anemia due to losartan in hypertensive renal transplant recipients without posttransplant erythrocytosis.
    Ersoy A; Kahvecioglu S; Ersoy C; Cift A; Dilek K
    Transplant Proc; 2005 Jun; 37(5):2148-50. PubMed ID: 15964363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early posttransplant erythrocytosis in renal allograft recipients.
    Prakash J; Singh S; Behur SK; Ghosh B; Sharatchandra LK; Dwivedi US
    J Assoc Physicians India; 2010 Sep; 58():574-6. PubMed ID: 21391381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of angiotensin-converting enzyme polymorphism gene, IGF-1, and other factors in the response rate of hematocrit to enalapril treatment in patients with posttransplant erythrocytosis.
    Jimeno L; Rodado R; Barrios Y; Campos M; Llorente S; Nicolas F; Minguela A
    Transplant Proc; 2005 Mar; 37(2):1012-3. PubMed ID: 15848608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of angiotensin I-converting enzyme polymorphism on development of post-transplant erythrocytosis in renal graft recipients.
    Kedzierska K; Kabat-Koperska J; Safranow K; Domański M; Gołembiewska E; Bober J; Bohatyrewicz R; Ciechanowski K
    Clin Transplant; 2008; 22(2):156-61. PubMed ID: 18339134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of enalapril and theophylline on polycythemia after renal transplantation.
    Ok E; Akçiçek F; Töz H; Kürşat S; Töbü M; Başçi A; Mees EJ
    Transplantation; 1995 Jun; 59(11):1623-6. PubMed ID: 7778179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.
    Zhu X; Chen J; Han F; Cheng M; Xu L; Zhang L; Ding X; Le Y
    Transplant Proc; 2009 Nov; 41(9):3736-42. PubMed ID: 19917377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia and erythrocytosis after kidney transplantation: a 5-year graft function and survival analysis.
    Kolonko A; Pinocy-Mańdok J; Kocierz M; Kujawa-Szewieczek A; Chudek J; Malyszko J; Malyszko JS; Myśliwiec M; Wiecek A
    Transplant Proc; 2009 Oct; 41(8):3046-51. PubMed ID: 19857673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocytosis after renal transplantation. A prospective analysis.
    Sumrani NB; Daskalakis P; Miles AM; Sarkar S; Markell MS; Hong JH; Friedman EA; Sommer BG
    ASAIO J; 1993; 39(1):51-5. PubMed ID: 8439681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness and safety of treatment with captopril in posttransplant erythrocytosis.
    Hernández E; Morales JM; Andrés A; Ortuño B; Praga M; Alcazar JM; Fernández G; Rodicio JL
    Transplant Proc; 1995 Aug; 27(4):2239-41. PubMed ID: 7652789
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship of posttransplantation erythrocytosis to hypercalcemia in renal transplant recipients.
    Akcay A; Kanbay M; Huddam B; Usluogullari CA; Arat Z; Ozdemir FN; Haberal M
    Transplant Proc; 2005 Sep; 37(7):3103-5. PubMed ID: 16213320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.